Chargement en cours...
2112. Voriconazole for Primary Prophylaxis: A Decade of Trends and Outcomes
BACKGROUND: Invasive fungal infections (IFI) continue to affect the immunocompromised patient population. Many of these patients require antifungal prophylaxis. Voriconazole is an azole antifungal that has been utilized for preventing IFIs but does not have an approved indication for prophylaxis. ME...
Enregistré dans:
| Publié dans: | Open Forum Infect Dis |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6809050/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1792 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|